Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mediator complex subunit 10 (MED10) is a protein component of the Mediator complex, a large multisubunit complex that acts as a transcriptional coactivator required for the regulated transcription of nearly all RNA polymerase II-dependent genes[2][3]. MED10 is localized to the middle module of the Mediator complex and plays a crucial structural and functional role in bridging gene-specific regulatory factors and the basal transcription machinery, including RNA polymerase II. Functional studies, primarily in model organisms such as yeast and supported by human gene data, show MED10 is involved in the assembly and stability of the preinitiation complex (PIC). Mutations in MED10 (or its homologs in other species) impair gene transcription globally by affecting the interaction and recruitment of general transcription factors (notably TFIIB and RNA polymerase II)[1]. There is no evidence that MED10 itself functions as a direct therapeutic target or biomarker; it is instead a core participant in the fundamental process of gene transcription regulation[2][3][1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mediator complex subunit 10 (MED10).